Clinical, genetic, and sociodemographic predictors of symptom severity after internet-delivered cognitive behavioural therapy for depression and anxiety

抑郁症和焦虑症患者接受互联网认知行为疗法后,临床、遗传和社会人口学因素对症状严重程度的预测作用

阅读:1

Abstract

BACKGROUND: Internet-delivered cognitive behavioural therapy (ICBT) is an effective and accessible treatment for mild to moderate depression and anxiety disorders. However, up to 50% of patients do not achieve sufficient symptom relief. Identifying patient characteristics predictive of higher post-treatment symptom severity is crucial for devising personalized interventions to avoid treatment failures and reduce healthcare costs. METHODS: Using the Swedish multimodal database MULTI-PSYCH, we evaluated novel and established predictors associated with treatment outcome and assessed the added benefit of polygenic risk scores (PRS) and nationwide register data in a sample of 2668 patients treated with ICBT for major depressive disorder, panic disorder, and social anxiety disorder. Two linear regression models were compared: a baseline model employing six well-established predictors and a full model incorporating six clinic-based, 32 register-based predictors, and PRS for seven psychiatric disorders and traits. Predictor importance was assessed through bivariate associations, and models were compared by the variance explained in post-treatment symptom scores. RESULTS: Our analysis identified several novel predictors of higher post-treatment severity, including comorbid ASD and ADHD, receipt of financial benefits, and prior use of psychotropic medications. The baseline model explained 27%, while the full model accounted for 34% of the variance. CONCLUSIONS: The findings suggest that a model incorporating a broad array of multimodal data offered a modest improvement in explanatory power compared to one using a limited set of easily accessible measures. Employing machine learning algorithms capable of capturing complex non-linear associations and interactions is a viable next step to improve prediction of post-ICBT symptom severity. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。